Treatment of experimental Escherichia coli pyelonephritis in rat by ciprofloxacin in comparison with tobramycin

Scand J Infect Dis. 1990;22(1):75-8. doi: 10.3109/00365549009023122.

Abstract

The ciprofloxacin efficacy was compared to that of tobramycin in an Escherichia coli pyelonephritis model in rat. Treatments started 48 h after ligation of the left ureter and inoculation of the bladder and continued for 5 days. Ciprofloxacin (2.5 mg/kg/d and 10 mg/kg/d) was administered intravenously either in a single daily dose or in 2 divided doses at 12 h intervals. Tobramycin (2.5 mg/kg/d and 10 mg/kg/d) was administered by the intramuscular route, in a single daily dose. Ciprofloxacin 10 mg/kg/d was as efficacious as tobramycin irrespective of dosage schedule. Ciprofloxacin 2.5 mg/kg/d was more effective when given twice a day than once.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Ciprofloxacin / administration & dosage
  • Ciprofloxacin / blood
  • Ciprofloxacin / therapeutic use*
  • Drug Administration Schedule
  • Escherichia coli Infections / drug therapy*
  • Injections, Intravenous
  • Male
  • Pyelonephritis / drug therapy*
  • Pyelonephritis / etiology
  • Rats
  • Rats, Inbred Strains
  • Tobramycin / administration & dosage
  • Tobramycin / blood
  • Tobramycin / therapeutic use*

Substances

  • Ciprofloxacin
  • Tobramycin